Methods and systems for subcutaneous graft implantation
    21.
    发明授权
    Methods and systems for subcutaneous graft implantation 有权
    用于皮下移植物植入的方法和系统

    公开(公告)号:US06682498B2

    公开(公告)日:2004-01-27

    申请号:US09816629

    申请日:2001-03-22

    Applicant: John Ross

    Inventor: John Ross

    Abstract: The present invention provides improved methods for establishing vascular access to a patient's body lumen or other target location, particularly blood vessels, for performing extracorporeal treatments, such as hemodialysis, hemofiltration, hemodiafiltration, plasmapheresis, apheresis, and the like, on circulating blood. In particular, the present invention provides improved methods which may enhance extracorporeal blood flow rates, reduce instances of fibrin sheath or thrombosis formation, and minimize recirculation effects. Methods for recirculating blood to a patient include placing a draw catheter so that a distal tip thereof is positioned in a right atrium of the patient's heart. A return catheter is placed so that a distal tip thereof is positioned in a superior vena cava. Extracorporeal blood flow from the draw catheter to the return catheter may then be established.

    Abstract translation: 本发明提供了用于在循环血液上建立对患者的体腔或其他目标位置,特别是血管的血管通路的改进方法,用于进行体外治疗,例如血液透析,血液滤过,血液透析滤过,血浆置换术,血浆置换术等。 特别地,本发明提供了改进的方法,其可以增强体外血流速度,减少纤维蛋白鞘或血栓形成的发生,并使再循环效应最小化。 将血液再循环到患者的方法包括放置牵引导管,使得其远端位于患者心脏的右心房中。 将返回导管放置成使其远端位于上腔静脉中。 然后可以建立从抽吸导管到返回导管的体外血流量。

    Front-loading syringe adapter for front-loading medical injector
    22.
    发明授权
    Front-loading syringe adapter for front-loading medical injector 失效
    用于前部装载式医用注射器的前装注射器适配器

    公开(公告)号:US06676634B1

    公开(公告)日:2004-01-13

    申请号:US09631422

    申请日:2000-08-03

    CPC classification number: A61M5/14546 A61M5/14566

    Abstract: The present syringe adapter (100), which permits use of syringes (40) of various types, sizes and configurations to be used with a front-loading injector (10), includes a removable injector face plate (120) having a releasable mounting mechanism (122a, 122b) for attaching the adapter face plate (120) to a front-load injector (10), a reducing sleeve (140) having a recess (190) for receiving the distal flange (44) of syringe (40), locking pivot arms (220, 240) pivotly attached to the reducing sleeve (140) to releasably engage syringe flange (44), and a piston extension (320) provided for extending the injector drive piston (16) for engagement with syringe plunger (46).

    Abstract translation: 本注射器适配器(100),其允许使用与前装载注射器(10)一起使用的各种类型,尺寸和构造的注射器(40),其包括可移除的注射器面板(120),其具有可释放的安装机构 用于将适配器面板(120)附接到前负载喷射器(10)的减压套筒(122a,122b),具有用于接收注射器(40)的远端凸缘(44)的凹部(190) 枢转地附接到所述还原套筒(140)以可释放地接合注射器凸缘(44)的枢转臂(220,240)和设置用于延伸所述注射器驱动活塞(16)以与注射器柱塞(46)接合的活塞延伸部 )。

    Method and apparatus for determining hemodialysis parameters
    24.
    发明授权
    Method and apparatus for determining hemodialysis parameters 失效
    用于确定血液透析参数的方法和装置

    公开(公告)号:US06648845B1

    公开(公告)日:2003-11-18

    申请号:US09003798

    申请日:1998-01-07

    Abstract: This invention provides a method and apparatus for calculating a hemodialysis parameter, especially blood access flow rate, using multiple dialysance values. The dialysance values may be calculated based upon either sodium or urea concentrations. One dialysance value can be determined for conditions in which a patient's arterial line withdraws blood from an upstream location in a patient's fistula and treated blood is returned by a venous line to a downstream location in a patient's fistula. The second dialysance value can be determined when the lines have been reconfigured so that the arterial line withdraws blood from a downstream portion of a patient's fistula and the venous line returns treated blood to an upstream portion of a patient's fistula. Since it is possible to determine the dialysance values solely from concentration measurements made on the dialysate side of the dialysis apparatus, the present method and apparatus provide a non-invasive means for determining hemodialysis parameters such as blood access flow rate and recirculation.

    Abstract translation: 本发明提供一种使用多个透析值计算血液透析参数,特别是血液存取流量的方法和装置。 透析值可以基于钠或尿素浓度来计算。 可以确定患者的动脉线从患者瘘管中的上游位置抽出血液的情况下的一个透析值,并且将经处理的血液通过静脉管线返回到患者瘘管的下游位置。 当线重新配置时,可以确定第二透析值,使得动脉线从患者瘘的下游部分抽出血液,并且静脉线将经处理的血液返回到患者瘘的上游部分。 由于可以仅通过在透析装置的透析液侧进行的浓度测定来确定透析值,因此本方法和装置提供用于确定血液透析参数如血液存取流量和再循环的非侵入性手段。

    Contrast injector for injecting a contrast medium to generate prolonged uniform vascular enhancement
    27.
    发明授权
    Contrast injector for injecting a contrast medium to generate prolonged uniform vascular enhancement 有权
    对比注射器用于注射造影剂以产生延长的均匀血管增强

    公开(公告)号:US06635030B1

    公开(公告)日:2003-10-21

    申请号:US09289289

    申请日:1999-04-09

    Abstract: A contrast medium injector for injecting a patient with contrast medium for a CT scan is programmed to provide an injection protocol that is a representation of an ideally defined exponential curve with an initial injection rate decaying at an exponential rate. This has been found to produce a uniform vascular enhancement for the scanning of a patient's blood vessels. The particular exponential decay coefficient which has been found to be optimal is directly proportional to the cardiac output divided by the patient's weight and is approximated at 0.01 for a typical human.

    Abstract translation: 用于向患者注射用于CT扫描的造影剂的造影剂注射器被编程以提供注射方案,其是以指数速率衰减的初始注射速率的理想定义的指数曲线的表示。 已经发现已经发现用于扫描患者血管的均匀的血管增强。 已经发现是最佳的特定指数衰减系数与心输出量除以患者体重成正比,对于典型的人而言,其近似为0.01。

    Method and device for the detection of stenosis in extra-corporeal blood treatment
    29.
    发明授权
    Method and device for the detection of stenosis in extra-corporeal blood treatment 有权
    用于检测体外血液治疗狭窄的方法和装置

    公开(公告)号:US06623443B1

    公开(公告)日:2003-09-23

    申请号:US09477198

    申请日:2000-01-04

    CPC classification number: A61M1/3639 A61M1/16 A61M1/3656 A61M2205/3344

    Abstract: Stenosis in a blood access circuit (graft, fistula) or in an extracorporeal circuit are detected by monitoring pressure pulses in the extracorporeal circuit created either by the heart or by the peristaltic blood pump of the extracorporeal circuit. By monitoring pressure pulses created by the. peristaltic blood pump loss of occlusion of the blood pump can be detected. Measurement of the pressure pulses is done either with sensors already built into the blood treatment equipment or, according to the invention, with sensors mechanically coupled to the wall of the blood tubing. The deviation of a pressure pulse amplitude proportional signal from a predetermined value indicates stenosis or loss of occlusion, respectively.

    Abstract translation: 通过监测由心脏或体外循环的蠕动血液泵产生的体外循环中的压力脉冲来检测血液存取回路(移植物,瘘管)或体外循环中的狭窄。 通过监测由...产生的压力脉冲。 可以检测到血液泵的蠕动性血液泵堵塞的损失。 压力脉冲的测量可以通过已经内置在血液处理设备中的传感器进行,或者根据本发明,机械耦合到血管的壁上的传感器。 来自预定值的压力脉冲幅度比例信号的偏差分别表示狭窄或闭塞丧失。

    Blood-purifying apparatus and artificial kidney using the same
    30.
    发明授权
    Blood-purifying apparatus and artificial kidney using the same 失效
    血液净化装置和使用其的人造肾

    公开(公告)号:US06623441B1

    公开(公告)日:2003-09-23

    申请号:US09744808

    申请日:2001-04-06

    CPC classification number: A61M1/3693 A61M1/3479 A61M1/3696

    Abstract: An artificial kidney capable of cleaning blood, like a kidney of a healthy body, by any person even at home which is small in the size and simple in the structure and handling, without requiring any pharmaceutical solution. A metabolic end product separation chamber (9) is placed to the center of a cylindrical centrifugator (7) for circulating blood continuously and separating it into blood cell ingredients and plasma ingredients for conducting ultrafiltration of the separated plasmas and intaking water, serum electrolytes and unnecessary metabolic end products, in which a water re-absorbing module (11) capable of flowing the concentrated plasma ingredients and re-absorbing the water content and the serum electrolytes to obtain a cleaned plasma ingredient is placed, and the obtained cleaned blood ingredients are mixed with the blood cell ingredients separated by the centrifugator (7) to obtain cleaned blood.

    Abstract translation: 一种人造肾,能够清洁血液,如健康身体的肾脏,甚至在家中,尺寸小,结构简单,处理方便,无需任何药物溶液。代谢终产物分离室(9 )放置在圆柱形离心机(7)的中心,用于连续循环血液,并将其分离成血细胞成分和血浆成分,用于对分离的血浆进行超滤并吸入水,血清电解质和不必要的代谢终产物,其中水 放置能够使浓缩的等离子体成分流通并再吸收含水量的再吸收组件(11)和血清电解质以获得清洁的血浆成分,并且将获得的清洁的血液成分与由 离心机(7)以获得清洁的血液。

Patent Agency Ranking